| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 108 | 2023 | 3110 | 7.210 |
Why?
|
| Mammography | 70 | 2019 | 458 | 4.810 |
Why?
|
| Artificial Intelligence | 25 | 2025 | 391 | 4.730 |
Why?
|
| Diagnosis, Computer-Assisted | 49 | 2025 | 337 | 4.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 57 | 2024 | 461 | 4.060 |
Why?
|
| Diagnostic Imaging | 20 | 2025 | 452 | 3.700 |
Why?
|
| Image Interpretation, Computer-Assisted | 31 | 2025 | 626 | 3.350 |
Why?
|
| Ultrasonography, Mammary | 20 | 2016 | 82 | 3.070 |
Why?
|
| Image Processing, Computer-Assisted | 49 | 2025 | 1261 | 2.840 |
Why?
|
| Radiographic Image Enhancement | 68 | 2019 | 449 | 2.830 |
Why?
|
| Breast | 16 | 2021 | 294 | 2.660 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2025 | 3476 | 2.440 |
Why?
|
| ROC Curve | 67 | 2023 | 775 | 2.400 |
Why?
|
| Machine Learning | 12 | 2025 | 341 | 1.920 |
Why?
|
| Radiology | 12 | 2022 | 192 | 1.890 |
Why?
|
| Algorithms | 39 | 2025 | 1953 | 1.640 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2022 | 55 | 1.380 |
Why?
|
| Image Enhancement | 15 | 2018 | 505 | 1.300 |
Why?
|
| Humans | 241 | 2025 | 93515 | 1.270 |
Why?
|
| Brain Injuries | 2 | 2022 | 164 | 1.230 |
Why?
|
| Tomography, X-Ray Computed | 27 | 2025 | 2585 | 1.170 |
Why?
|
| Radiography, Thoracic | 27 | 2024 | 327 | 1.140 |
Why?
|
| Female | 141 | 2025 | 48702 | 1.110 |
Why?
|
| Lupus Nephritis | 5 | 2022 | 78 | 0.980 |
Why?
|
| Data Curation | 2 | 2025 | 10 | 0.970 |
Why?
|
| Radiography | 15 | 2018 | 790 | 0.930 |
Why?
|
| Health Information Interoperability | 1 | 2025 | 7 | 0.920 |
Why?
|
| Retrospective Studies | 36 | 2025 | 10164 | 0.920 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2015 | 165 | 0.900 |
Why?
|
| Pattern Recognition, Automated | 16 | 2013 | 217 | 0.870 |
Why?
|
| Thyroid Nodule | 1 | 2025 | 60 | 0.830 |
Why?
|
| Early Detection of Cancer | 6 | 2025 | 482 | 0.810 |
Why?
|
| Sensitivity and Specificity | 42 | 2024 | 1922 | 0.790 |
Why?
|
| Lymph Nodes | 3 | 2015 | 548 | 0.770 |
Why?
|
| Middle Aged | 53 | 2025 | 27573 | 0.760 |
Why?
|
| Emphysema | 1 | 2023 | 24 | 0.750 |
Why?
|
| Pulmonary Emphysema | 1 | 2023 | 43 | 0.740 |
Why?
|
| Health Physics | 5 | 2022 | 22 | 0.700 |
Why?
|
| Magnets | 1 | 2021 | 13 | 0.690 |
Why?
|
| Cells | 1 | 2021 | 30 | 0.680 |
Why?
|
| Radiometry | 4 | 2023 | 60 | 0.670 |
Why?
|
| Microscopy | 1 | 2021 | 89 | 0.670 |
Why?
|
| Adult | 49 | 2025 | 27918 | 0.660 |
Why?
|
| Calcaneus | 4 | 2010 | 41 | 0.650 |
Why?
|
| Aged | 44 | 2025 | 20434 | 0.650 |
Why?
|
| Organ Specificity | 1 | 2021 | 279 | 0.640 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1448 | 0.640 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 103 | 0.630 |
Why?
|
| Breast Diseases | 14 | 2018 | 99 | 0.630 |
Why?
|
| Medical Informatics | 2 | 2024 | 48 | 0.600 |
Why?
|
| Physics | 2 | 2018 | 21 | 0.580 |
Why?
|
| Risk Assessment | 7 | 2019 | 2441 | 0.570 |
Why?
|
| Heart Arrest | 1 | 2022 | 311 | 0.560 |
Why?
|
| Research Report | 1 | 2018 | 43 | 0.560 |
Why?
|
| Databases, Factual | 11 | 2018 | 1006 | 0.530 |
Why?
|
| Radiotherapy | 2 | 2020 | 320 | 0.530 |
Why?
|
| Societies, Scientific | 1 | 2018 | 41 | 0.530 |
Why?
|
| Mammary Glands, Human | 2 | 2014 | 26 | 0.530 |
Why?
|
| Societies, Medical | 3 | 2024 | 621 | 0.520 |
Why?
|
| Aged, 80 and over | 25 | 2019 | 7061 | 0.520 |
Why?
|
| Contrast Media | 15 | 2021 | 988 | 0.520 |
Why?
|
| Reproducibility of Results | 29 | 2022 | 2715 | 0.520 |
Why?
|
| Axilla | 2 | 2014 | 109 | 0.520 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 185 | 0.510 |
Why?
|
| Lung Neoplasms | 14 | 2025 | 2365 | 0.510 |
Why?
|
| Lung | 15 | 2024 | 1366 | 0.490 |
Why?
|
| False Positive Reactions | 23 | 2014 | 212 | 0.470 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 504 | 0.470 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2014 | 608 | 0.470 |
Why?
|
| Biomedical Research | 5 | 2012 | 438 | 0.470 |
Why?
|
| Calcinosis | 16 | 2010 | 222 | 0.460 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 84 | 0.440 |
Why?
|
| Genes, BRCA2 | 3 | 2014 | 162 | 0.440 |
Why?
|
| Genes, BRCA1 | 4 | 2014 | 191 | 0.430 |
Why?
|
| Genomics | 2 | 2019 | 848 | 0.410 |
Why?
|
| Absorptiometry, Photon | 5 | 2007 | 109 | 0.400 |
Why?
|
| Diagnosis, Differential | 16 | 2018 | 1546 | 0.400 |
Why?
|
| Neoplasms | 6 | 2020 | 3169 | 0.390 |
Why?
|
| Carcinoma | 2 | 2016 | 439 | 0.390 |
Why?
|
| Area Under Curve | 14 | 2014 | 335 | 0.380 |
Why?
|
| Artifacts | 5 | 2018 | 243 | 0.380 |
Why?
|
| Breast Density | 4 | 2019 | 37 | 0.380 |
Why?
|
| Solitary Pulmonary Nodule | 8 | 2002 | 139 | 0.370 |
Why?
|
| Radiography, Interventional | 5 | 2016 | 148 | 0.350 |
Why?
|
| Subtraction Technique | 9 | 2011 | 125 | 0.350 |
Why?
|
| Observer Variation | 16 | 2024 | 570 | 0.350 |
Why?
|
| Ultrasonography | 6 | 2025 | 702 | 0.330 |
Why?
|
| Catheterization | 4 | 2016 | 218 | 0.330 |
Why?
|
| User-Computer Interface | 3 | 2010 | 189 | 0.330 |
Why?
|
| Biopsy | 11 | 2021 | 1175 | 0.320 |
Why?
|
| Bone Density | 11 | 2010 | 237 | 0.320 |
Why?
|
| Movement | 3 | 2007 | 304 | 0.320 |
Why?
|
| Phenotype | 8 | 2022 | 2544 | 0.320 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 394 | 0.300 |
Why?
|
| Tumor Burden | 3 | 2019 | 321 | 0.290 |
Why?
|
| Pilot Projects | 9 | 2025 | 917 | 0.270 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2018 | 113 | 0.270 |
Why?
|
| Predictive Value of Tests | 7 | 2018 | 1713 | 0.260 |
Why?
|
| Radiologists | 2 | 2024 | 53 | 0.240 |
Why?
|
| Information Dissemination | 2 | 2025 | 124 | 0.240 |
Why?
|
| Male | 28 | 2025 | 44557 | 0.230 |
Why?
|
| Technology, Radiologic | 9 | 1996 | 103 | 0.230 |
Why?
|
| Mass Screening | 7 | 2025 | 696 | 0.230 |
Why?
|
| Data Collection | 2 | 2013 | 370 | 0.230 |
Why?
|
| Mutation | 6 | 2015 | 4272 | 0.230 |
Why?
|
| Biological Science Disciplines | 1 | 2025 | 14 | 0.220 |
Why?
|
| Adnexal Diseases | 1 | 2025 | 22 | 0.220 |
Why?
|
| Gastrostomy | 2 | 2016 | 66 | 0.220 |
Why?
|
| Catheters | 2 | 2016 | 96 | 0.220 |
Why?
|
| Fetus | 2 | 2023 | 236 | 0.220 |
Why?
|
| Precision Medicine | 2 | 2019 | 456 | 0.210 |
Why?
|
| Biomarkers | 4 | 2022 | 1910 | 0.210 |
Why?
|
| Catheters, Indwelling | 2 | 2014 | 101 | 0.200 |
Why?
|
| Head Injuries, Penetrating | 1 | 2025 | 67 | 0.200 |
Why?
|
| Neuroimaging | 1 | 2025 | 132 | 0.200 |
Why?
|
| Hydronephrosis | 1 | 2023 | 30 | 0.200 |
Why?
|
| Software | 11 | 2023 | 670 | 0.200 |
Why?
|
| Computer Simulation | 7 | 2014 | 1118 | 0.190 |
Why?
|
| Wounds, Gunshot | 1 | 2025 | 121 | 0.190 |
Why?
|
| Technology Assessment, Biomedical | 3 | 2012 | 24 | 0.190 |
Why?
|
| Phantoms, Imaging | 7 | 2023 | 484 | 0.190 |
Why?
|
| Forecasting | 3 | 2020 | 293 | 0.180 |
Why?
|
| Lung Diseases | 8 | 2024 | 283 | 0.180 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2025 | 259 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2025 | 367 | 0.180 |
Why?
|
| Heart | 3 | 2010 | 522 | 0.180 |
Why?
|
| Young Adult | 9 | 2025 | 6930 | 0.180 |
Why?
|
| Coma | 1 | 2021 | 45 | 0.170 |
Why?
|
| Osteoporosis | 5 | 2010 | 129 | 0.170 |
Why?
|
| NADP | 1 | 2021 | 48 | 0.170 |
Why?
|
| Models, Statistical | 6 | 2008 | 585 | 0.170 |
Why?
|
| Hormones | 1 | 2021 | 136 | 0.170 |
Why?
|
| Data Mining | 2 | 2018 | 44 | 0.160 |
Why?
|
| Radiation Oncology | 1 | 2022 | 124 | 0.160 |
Why?
|
| Information Storage and Retrieval | 5 | 2025 | 126 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2025 | 4560 | 0.160 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 179 | 0.160 |
Why?
|
| Staining and Labeling | 1 | 2021 | 158 | 0.160 |
Why?
|
| Radiation Dosage | 6 | 2025 | 229 | 0.160 |
Why?
|
| Angiography | 7 | 1995 | 192 | 0.150 |
Why?
|
| Risk Factors | 10 | 2014 | 5899 | 0.150 |
Why?
|
| Education, Medical | 1 | 2022 | 228 | 0.150 |
Why?
|
| Parenchymal Tissue | 1 | 2019 | 7 | 0.150 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 17 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2021 | 202 | 0.140 |
Why?
|
| Bayes Theorem | 7 | 2013 | 402 | 0.140 |
Why?
|
| Adolescent | 8 | 2025 | 9606 | 0.140 |
Why?
|
| Gadolinium DTPA | 5 | 2014 | 233 | 0.140 |
Why?
|
| Documentation | 2 | 2010 | 97 | 0.140 |
Why?
|
| Television | 4 | 1986 | 28 | 0.140 |
Why?
|
| Pandemics | 2 | 2021 | 873 | 0.140 |
Why?
|
| Workflow | 1 | 2018 | 77 | 0.140 |
Why?
|
| Osteolysis | 2 | 2008 | 13 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 429 | 0.140 |
Why?
|
| Densitometry | 3 | 2010 | 23 | 0.140 |
Why?
|
| Computer Systems | 4 | 2000 | 64 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2020 | 362 | 0.130 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2802 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2018 | 187 | 0.130 |
Why?
|
| Kidney | 3 | 2022 | 1111 | 0.130 |
Why?
|
| Models, Theoretical | 7 | 2009 | 494 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 1998 | 149 | 0.130 |
Why?
|
| Likelihood Functions | 3 | 2013 | 256 | 0.120 |
Why?
|
| History, 20th Century | 1 | 2018 | 314 | 0.120 |
Why?
|
| Nephritis, Interstitial | 1 | 2016 | 44 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2018 | 218 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 2465 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Hip | 2 | 2008 | 99 | 0.120 |
Why?
|
| Time Factors | 8 | 2015 | 5410 | 0.120 |
Why?
|
| Teleradiology | 1 | 1996 | 4 | 0.120 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 1660 | 0.120 |
Why?
|
| Inflammation | 3 | 2022 | 1050 | 0.120 |
Why?
|
| United States | 7 | 2022 | 7622 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 11 | 2012 | 242 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1170 | 0.110 |
Why?
|
| X-Ray Intensifying Screens | 5 | 1993 | 34 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 203 | 0.110 |
Why?
|
| Biophysical Phenomena | 12 | 2000 | 124 | 0.110 |
Why?
|
| Biophysics | 12 | 2000 | 153 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 3911 | 0.110 |
Why?
|
| Femur Neck | 5 | 2006 | 42 | 0.110 |
Why?
|
| Device Approval | 2 | 2012 | 14 | 0.110 |
Why?
|
| Cardiomegaly | 2 | 2014 | 111 | 0.110 |
Why?
|
| Colonic Diseases | 1 | 2015 | 59 | 0.110 |
Why?
|
| Kinetics | 3 | 2013 | 1492 | 0.110 |
Why?
|
| Fourier Analysis | 7 | 2014 | 123 | 0.110 |
Why?
|
| Manganese | 1 | 2014 | 56 | 0.110 |
Why?
|
| Atherosclerosis | 2 | 2007 | 256 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Probability | 3 | 2014 | 355 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2019 | 536 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2016 | 454 | 0.110 |
Why?
|
| Primary Health Care | 1 | 1998 | 378 | 0.110 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 6 | 0.110 |
Why?
|
| Fuzzy Logic | 4 | 2010 | 16 | 0.110 |
Why?
|
| Datasets as Topic | 1 | 2014 | 81 | 0.100 |
Why?
|
| Thorax | 1 | 2014 | 78 | 0.100 |
Why?
|
| Apoptosis | 2 | 2019 | 1721 | 0.100 |
Why?
|
| Sutures | 1 | 2014 | 58 | 0.100 |
Why?
|
| Biomechanical Phenomena | 3 | 2013 | 489 | 0.100 |
Why?
|
| Gene Expression | 2 | 2016 | 1301 | 0.100 |
Why?
|
| Holistic Health | 1 | 1993 | 9 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 2014 | 111 | 0.100 |
Why?
|
| Philosophy, Medical | 1 | 1993 | 17 | 0.100 |
Why?
|
| Risk | 2 | 2013 | 657 | 0.100 |
Why?
|
| Heterozygote | 1 | 2014 | 382 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2014 | 228 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1518 | 0.100 |
Why?
|
| Expert Systems | 1 | 1993 | 18 | 0.100 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 1993 | 12 | 0.100 |
Why?
|
| Confidence Intervals | 3 | 2012 | 217 | 0.100 |
Why?
|
| Suture Techniques | 1 | 2014 | 142 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2022 | 1090 | 0.100 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 149 | 0.100 |
Why?
|
| Motion | 1 | 2013 | 94 | 0.100 |
Why?
|
| Discriminant Analysis | 6 | 2013 | 64 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2014 | 179 | 0.100 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 184 | 0.090 |
Why?
|
| Complementary Therapies | 1 | 1993 | 53 | 0.090 |
Why?
|
| Professional Competence | 1 | 2013 | 66 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 242 | 0.090 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 68 | 0.090 |
Why?
|
| Calcium | 2 | 2014 | 1176 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2015 | 272 | 0.090 |
Why?
|
| BRCA2 Protein | 5 | 2008 | 173 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 109 | 0.090 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 1775 | 0.090 |
Why?
|
| Educational Status | 1 | 2013 | 197 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 1275 | 0.090 |
Why?
|
| Attitude | 1 | 2013 | 132 | 0.090 |
Why?
|
| X-Ray Film | 8 | 1994 | 37 | 0.090 |
Why?
|
| Preventive Health Services | 1 | 2011 | 38 | 0.090 |
Why?
|
| Linear Models | 2 | 2009 | 413 | 0.090 |
Why?
|
| Equipment Failure Analysis | 3 | 2010 | 88 | 0.080 |
Why?
|
| Genome, Human | 1 | 2015 | 823 | 0.080 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 77 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 297 | 0.080 |
Why?
|
| Research Design | 1 | 2014 | 617 | 0.080 |
Why?
|
| Radiology Information Systems | 5 | 1999 | 78 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2017 | 0.080 |
Why?
|
| Animals | 5 | 2021 | 28155 | 0.080 |
Why?
|
| Diagnostic Errors | 5 | 2002 | 157 | 0.080 |
Why?
|
| Anthropometry | 1 | 2010 | 75 | 0.080 |
Why?
|
| Spinal Fractures | 2 | 2010 | 102 | 0.080 |
Why?
|
| Quality of Life | 1 | 1998 | 1780 | 0.080 |
Why?
|
| Bone and Bones | 3 | 2000 | 273 | 0.070 |
Why?
|
| Chicago | 2 | 2012 | 1464 | 0.070 |
Why?
|
| Fractals | 6 | 2008 | 41 | 0.070 |
Why?
|
| Equipment Design | 4 | 2015 | 416 | 0.070 |
Why?
|
| Reference Standards | 2 | 2023 | 146 | 0.070 |
Why?
|
| BRCA1 Protein | 3 | 2008 | 214 | 0.070 |
Why?
|
| Automation | 5 | 2014 | 105 | 0.070 |
Why?
|
| Fractures, Bone | 3 | 2006 | 155 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 1989 | 118 | 0.070 |
Why?
|
| Fibrocystic Breast Disease | 2 | 2005 | 12 | 0.070 |
Why?
|
| Filtration | 2 | 2006 | 27 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2021 | 436 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 1073 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 1847 | 0.060 |
Why?
|
| Bias | 2 | 2014 | 137 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 32 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 1243 | 0.060 |
Why?
|
| Regression Analysis | 5 | 2010 | 579 | 0.060 |
Why?
|
| Metadata | 1 | 2025 | 3 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 3147 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 92 | 0.060 |
Why?
|
| Age Factors | 4 | 2014 | 1906 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 2011 | 189 | 0.050 |
Why?
|
| Computers | 3 | 2000 | 102 | 0.050 |
Why?
|
| Copying Processes | 2 | 1994 | 6 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 356 | 0.050 |
Why?
|
| Databases as Topic | 5 | 2002 | 96 | 0.050 |
Why?
|
| Public Health | 1 | 2025 | 153 | 0.050 |
Why?
|
| Biomedical Engineering | 1 | 2003 | 21 | 0.050 |
Why?
|
| Mathematics | 6 | 1995 | 180 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 300 | 0.050 |
Why?
|
| Genetic Carrier Screening | 1 | 2002 | 58 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 225 | 0.050 |
Why?
|
| Neoplasm Grading | 2 | 2016 | 402 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2023 | 191 | 0.050 |
Why?
|
| Abdomen | 1 | 2023 | 120 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2010 | 391 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2025 | 482 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 876 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2015 | 9099 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2021 | 102 | 0.040 |
Why?
|
| Incidence | 2 | 2012 | 1701 | 0.040 |
Why?
|
| United States Food and Drug Administration | 2 | 2012 | 142 | 0.040 |
Why?
|
| Colonic Polyps | 1 | 2001 | 137 | 0.040 |
Why?
|
| Ribs | 2 | 1998 | 49 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 302 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2002 | 381 | 0.040 |
Why?
|
| China | 1 | 2020 | 264 | 0.040 |
Why?
|
| Heart Rate | 2 | 2014 | 505 | 0.040 |
Why?
|
| Models, Structural | 3 | 1993 | 53 | 0.040 |
Why?
|
| Lasers | 3 | 1993 | 101 | 0.040 |
Why?
|
| Switzerland | 1 | 1998 | 19 | 0.040 |
Why?
|
| Visual Perception | 1 | 2022 | 334 | 0.040 |
Why?
|
| Absenteeism | 1 | 1998 | 10 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 425 | 0.030 |
Why?
|
| Liver | 2 | 2013 | 1210 | 0.030 |
Why?
|
| Life Change Events | 1 | 1998 | 46 | 0.030 |
Why?
|
| Somatoform Disorders | 1 | 1998 | 31 | 0.030 |
Why?
|
| Acceleration | 2 | 2007 | 20 | 0.030 |
Why?
|
| Diaphragm | 1 | 1998 | 75 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2018 | 196 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 627 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2017 | 135 | 0.030 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 2017 | 51 | 0.030 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2016 | 25 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 2016 | 32 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2022 | 822 | 0.030 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 41 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 603 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 413 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 1 | 2016 | 88 | 0.030 |
Why?
|
| Germinal Center | 1 | 2016 | 62 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2004 | 196 | 0.030 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 121 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 98 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1914 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 282 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 3220 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1587 | 0.030 |
Why?
|
| Diastole | 1 | 2014 | 99 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 894 | 0.030 |
Why?
|
| Brain | 1 | 2025 | 2391 | 0.030 |
Why?
|
| Models, Biological | 3 | 2006 | 1768 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2016 | 331 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1997 | 226 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 42 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 362 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 572 | 0.030 |
Why?
|
| Colectomy | 1 | 2015 | 192 | 0.030 |
Why?
|
| Mice | 2 | 2019 | 12269 | 0.030 |
Why?
|
| Anthroposophy | 1 | 1993 | 1 | 0.030 |
Why?
|
| Homeopathy | 1 | 1993 | 1 | 0.030 |
Why?
|
| Chiropractic | 1 | 1993 | 2 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1993 | 9 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 133 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 449 | 0.020 |
Why?
|
| Plants, Medicinal | 1 | 1993 | 39 | 0.020 |
Why?
|
| Multigene Family | 1 | 2014 | 203 | 0.020 |
Why?
|
| Acute Disease | 1 | 2015 | 841 | 0.020 |
Why?
|
| Cell Communication | 1 | 2014 | 216 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 3830 | 0.020 |
Why?
|
| Risk Management | 1 | 2012 | 38 | 0.020 |
Why?
|
| Mass Chest X-Ray | 1 | 1992 | 5 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1992 | 104 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1799 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 278 | 0.020 |
Why?
|
| Child | 1 | 2023 | 7355 | 0.020 |
Why?
|
| Water | 1 | 2014 | 307 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 206 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 1996 | 454 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 700 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 1190 | 0.020 |
Why?
|
| Computer Graphics | 1 | 2012 | 100 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 985 | 0.020 |
Why?
|
| Spine | 1 | 1993 | 150 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1117 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1105 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 580 | 0.020 |
Why?
|
| Thoracic Diseases | 1 | 1991 | 28 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2016 | 1120 | 0.020 |
Why?
|
| Spectrum Analysis | 2 | 1991 | 119 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1007 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1139 | 0.020 |
Why?
|
| Conflict of Interest | 1 | 2011 | 70 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 578 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 650 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 337 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 870 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2009 | 37 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2121 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 478 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 701 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1994 | 1931 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1866 | 0.020 |
Why?
|
| Biometry | 2 | 1986 | 70 | 0.020 |
Why?
|
| Xenon Radioisotopes | 2 | 2000 | 9 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 2 | 2000 | 11 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 234 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1989 | 207 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2000 | 948 | 0.020 |
Why?
|
| Lumbar Vertebrae | 2 | 2006 | 358 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2495 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1990 | 408 | 0.020 |
Why?
|
| Heart Diseases | 1 | 1990 | 257 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3435 | 0.020 |
Why?
|
| Differential Threshold | 1 | 1987 | 11 | 0.020 |
Why?
|
| Electricity | 1 | 1987 | 24 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 117 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 1986 | 7 | 0.020 |
Why?
|
| Hip Joint | 1 | 2006 | 56 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2484 | 0.010 |
Why?
|
| Analog-Digital Conversion | 1 | 1984 | 8 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1321 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 570 | 0.010 |
Why?
|
| Weights and Measures | 1 | 1984 | 7 | 0.010 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2004 | 33 | 0.010 |
Why?
|
| Breast Cyst | 1 | 2004 | 4 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2005 | 150 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1990 | 1077 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2003 | 89 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1999 | 86 | 0.010 |
Why?
|
| Joint Diseases | 1 | 1999 | 47 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 156 | 0.010 |
Why?
|
| Femur | 1 | 2000 | 107 | 0.010 |
Why?
|
| Fibroadenoma | 1 | 1999 | 7 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2000 | 248 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 674 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 1053 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1998 | 42 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 537 | 0.010 |
Why?
|
| Information Systems | 1 | 1995 | 29 | 0.010 |
Why?
|
| Printing | 1 | 1994 | 4 | 0.010 |
Why?
|
| Mediastinum | 1 | 1994 | 43 | 0.010 |
Why?
|
| Radiography, Abdominal | 1 | 1993 | 63 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1993 | 231 | 0.010 |
Why?
|
| Japan | 1 | 1992 | 299 | 0.010 |
Why?
|
| Databases, Bibliographic | 1 | 1991 | 17 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2000 | 1691 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1993 | 152 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1991 | 64 | 0.010 |
Why?
|
| Decision Trees | 1 | 1990 | 64 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1991 | 51 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1993 | 492 | 0.010 |
Why?
|
| Illinois | 1 | 1990 | 520 | 0.000 |
Why?
|
| Models, Anatomic | 1 | 1988 | 87 | 0.000 |
Why?
|
| Hand | 1 | 1988 | 143 | 0.000 |
Why?
|
| Decision Theory | 1 | 1986 | 3 | 0.000 |
Why?
|